Gastro Health – Alexandria – Beauregard
1800 N. Beauregard St.
Suite 200
Alexandria, VA 22311
Gastro Health – Alexandria – Kenmore
4660 Kenmore Ave.
Suite 810
Alexandria, VA 22304
Gastro Health – Annandale
7004-A Little River Turnpike
Annandale, VA 22003
Gastro Health – Chantilly
3914 Centreville Rd.
Suite 350
Chantilly, VA 20151
Gastro Health – Fair Oaks
3700 Joseph Siewick Dr.
Suite 308
Fairfax, VA 22033
Gastro Health – Fairfax
3028 Javier Rd.
Suite 300
Fairfax, VA 22031
Gastro Health – Manassas
8140 Ashton Ave.
Suite 212
Manassas, VA 20109
Gastro Health – Mount Vernon
2616 Sherwood Hall Ln.
Suite 203
Alexandria, VA 22306
Gastro Health – Reston
1939 Roland Clarke Pl.
Suite 200
Reston, VA 20191
Gastro Health – Stafford
422 Garrisonville Rd.
Suite 109
Stafford, VA 22554
Gastro Health – Woodbridge
14010 Smoketown Rd.
Suite 117
Woodbridge, VA 22192
Gastroesophageal Reflux Disease (GERD): A New and Effective Treatment Option
About GERD
GERD is a common gastrointestinal disease affecting nearly 20 percent of Americans. It is a chronic health condition in which the gastroesophageal valve allows stomach acid to regurgitate backwards into the esophagus, causing heartburn and possible injury to the esophageal lining. It is the most common gastrointestinal-related diagnosis physicians make during clinical visits. Some patients may have mild or moderate symptoms, while others experience more severe symptoms such as chronic heartburn, asthma, chronic cough, a hoarse voice or chest pain.
Why Treat GERD?
Left untreated, GERD can develop into pre-cancerous conditions such as Barrett’s esophagus, which can be a precursor to developing esophageal cancer. Initial treatment recommendations for patients with GERD is to make lifestyle changes in diet, eating schedule and/or sleeping position. Proton pump inhibitor (PPI) medications are often used to treat GERD, but some clinical studies suggest there may be residual risks associated with long term PPI use.
About The TIF Procedure
In just under an hour, the transoral incisionless fundoplication (TIF 2.0) procedure safely and effectively treats moderate to severe GERD by introducing the EsophyX® device into the body through the mouth, not through an incision.
The TIF 2.0 procedure corrects the dysfunctional anatomy by reconstructing an anti-reflux valve at the gastroesophageal junction and reducing any small hiatal hernias. This procedure fills the treatment gap between medical therapy and traditional surgical solutions. Most patients can go home the same day and return to work and most normal activities within a few days. Clinical studies show that 80% of patients remain off daily PPIs at three years following the procedure.
Over 22,000 TIF procedures have been performed worldwide. More than 100 peer-reviewed papers have consistently documented the sustained improved clinical outcomes and exemplary safety profile the TIF procedure provides to patients suffering from GERD.
About Insurance Coverage
With the support of clinical societies, commercial and federal insurance providers, representing more than 100 million lives, have recognized the value of the TIF 2.0 procedure through recently expanded coverage. The procedure is covered by Medicare across the country.
Who would benefit from this procedure?
The TIF procedure is a good solution for moderate-to-severe GERD patients who are:
• Dissatisfied with pharmaceutical therapies and the burdensome lifestyle changes (sleeping, eating…) that they are forced to make to manage symptoms
• Suffering from non-acid symptoms of reflux such as asthma, persistent cough or sore throat
• Concerned about the potential long-term side effects from dependence on proton pump inhibitors
